Erythropoietin, heme oxygenase-1 and vascular tissue protective effects

Clinical Nephrology

Volumn 71, Issue 3, 2009, Pages 365-366

  Davis, P A ^a   Mormino, P ^b   Calo L A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEME OXYGENASE 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTOPORPHYRIN COBALT; RECOMBINANT ERYTHROPOIETIN;

ANTIINFLAMMATORY ACTIVITY; BLOOD PRESSURE; ENDOTHELIUM CELL; GENE EXPRESSION; HEMODIALYSIS; HUMAN; LETTER; NONHUMAN; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASODILATATION; ANIMAL; DRUG EFFECT; KIDNEY FAILURE; METABOLISM; RENAL REPLACEMENT THERAPY;

ANIMALS; ENDOTHELIUM, VASCULAR; ERYTHROPOIETIN, RECOMBINANT; HEME OXYGENASE-1; HUMANS; KIDNEY FAILURE; RENAL DIALYSIS;

EID: 65449127765     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP71365     Document Type: Letter

References (13)

1. Ahmad M, Turkseven S, Mingone CJ, Gupte SA, Wolin MS, Abraham NG. Heme oxygenase-1 gene expression increases vascular relaxation and decreases inducible nitric oxide synthase in diabetic rats. Cell Mol Biol. 2005; 51: 371-376.
2. Calo LA, Stanic L, Davis PA, Pagnin E, Munaretto G, Fusaro M, Landini S, Semplicini A, Piccoli A. Effect of epoetin on HO-1m RNA level and plasma antioxidants in hemodialysis patients. Int J Clin Pharmacol Ther. 2003; 41: 187-192.
3. Calo LA, Davis PA, Piccoli A, Pessina AC. Arole for heme oxygenase-1 in the antioxidant and antiapoptotic effects of erythropoietin: the start of a good news/bad news story? Nephron Physiol. 2006; 103: 107-111.
4. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, Rütten H, Fichtlscherer S, Martin H, Zeiher AM. HMG-Co A reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest. 2001; 108: 391-397.
5. Durante W. Heme oxygenase-1 in growth control and its clinical application to vascular disease. J Cell Physiol. 2003; 195: 373-382.
6. Fliser D, Bahlmann FH. Erythropoietin and the endothelium - a promising link? Eur J Clin Invest. 2008; 38: 457-461.
7. Goldman SA, Nedergaard M. Erythropoietin strikes a new cord. Nat Med. 2002; 8: 785-787.
8. Imai T, Morita T, Shindo T, Nagai R, Yazaki Y, Kurihara H, Suematsu M, Katayama S. Vascular smooth muscle cell-directed overexpression of heme oxygenase-1 elevates blood pressure through attenuation of nitric oxide-induced vasodilation in mice. Circ Res. 2001; 89: 55-62.
9. Kawamura K, Ishikawa K, Wada Y, Kimura S, Matsmoto H, Kohro T, Itabe H, Kodama T, Maruyama Y. Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction. Arterioscler Thromb Vasc Biol. 2005; 25: 155-160.
10. Lee TS, Chang CC, Zhu Y, Shyy JY. Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation. 2004; 110: 1296-1302.
11. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol. 1997; 37: 517-554.
12. Martin D, Rojo AI, Salinas M, Diaz R, Gallardo G, Alam J, De Galarreta CM, Cuadrado A. Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol. J Biol Chem. 2004; 279: 8919-8929.
13. Stec DE, Vera T, McLemore GR Jr, Kelsen S, Rimoldi JM, Gadepalli RS, Ryan MJ. Heme oxygenase-1 induction does not improve vascular relaxation in angiotensin II hypertensive mice. Am J Hypertens. 2008; 21: 189-193.